Verse Is Waiting on Average Right Now

Luke: We are inverting the classical drug development time line to put kids first. Verse is waiting on average right now six and a half years after the first adult. The innovation was, how do we move faster for the company, allying incentives for these patients who have been left behind? And so we are going after indications that are genetically defined and have no standard of care.